Before starting to work for Vapotherm, I was the Respiratory Director at a 450 bed hospital in Virginia. Now that I work with other Respiratory Directors as a Vapotherm Area Clinical Manager, I encounter many clients who appreciate the value of the technology as a viable alternative to noninvasive positive pressure therapy (NIPPV).
Noninvasive Respiratory Support Selection: Impact on Hospital Reimbursement and Respiratory Department Productivity and Billing
Although thousands of US Short-Term Acute Care (STAC) hospitals commonly use High Flow Nasal Cannula (HFNC) in one or more care areas within their facilities, there remains hospitals that do not use HFNC at all or use it in a limited fashion. This often is due to perceived concerns that greater adoption of the technology in the hospital may negatively impact hospital revenue and respiratory department performance measurements associated with productivity and billing.